The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of resection of the primary in metastatic well/intermediate-differentiated neuroendocrine tumor (NET).
 
Walid Labib Shaib
Research Funding - ArQule (Inst); Lilly (Inst)
 
Mckenna Penely
No Relationships to Disclose
 
Katerina Mary Zakka
No Relationships to Disclose
 
Renjian Jiang
No Relationships to Disclose
 
Mehmet Akce
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical; Polaris; RedHill Biopharma; Tesaro
 
Christina Wu
Research Funding - Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Lycera (Inst); Seagen (Inst); Symphogen (Inst); Vaccinex (Inst)
 
Madhusmita Behera
No Relationships to Disclose
 
Shishir K. Maithel
No Relationships to Disclose
 
Juan Sarmiento
No Relationships to Disclose
 
Olatunji B. Alese
Consulting or Advisory Role - AstraZeneca; Conjupro Biotherapeutics; Exelixis; Purdue Pharma
Research Funding - Acetylon Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)